معرفی
Lene Wohlfahrt Dreyer is a Clinical Professor of Rheumatology and Head of the Centre of Rheumatic Research Aalborg (CERRA) at Aalborg University. She leads a multidisciplinary team conducting internationally recognized research in rheumatology, with a focus on personalized medicine, biologic therapies, and comorbidity management. Her work integrates epidemiological, clinical, and laboratory research methods.
Research interests include treatment efficacy/safety for rheumatic diseases, polyautoimmunity, immunology, and multimorbidity impacts on patient outcomes. CERRA collaborates with institutions like Oxford University on Big Data projects, AI applications, and spine databases. Dr. Dreyer has supervised 4 PhD students and teaches at undergraduate and postgraduate levels in rheumatology and internal medicine.
Her recent publications analyze treatment burden in spinal pain patients, cancer risks with biologics, and sex differences in rheumatoid arthritis outcomes. She actively engages in clinical trials and registry-based research using national health datasets. Media coverage highlights her contributions to CAR-T cell therapy advancements and cannabis-based pain management debates.
Labs/Teams: CERRA collaborates with global partners on projects like lymphocyte activation gene studies and AI-driven personalized medicine initiatives. Current strategic priorities include musculoskeletal databases and translational research bridging basic science and clinical practice.
